Making a Community Impact: How your organization can secure opioid settlement funding and execute a successful at-home drug deactivation and disposal campaign

Almost one million Americans* have died from drug overdoses since 1999, and between 1999 and 2019 more than 500,000 of those deaths were attributed to opioid and prescription use. Additionally, for every drug overdose death there are many more nonfatal overdoses.
There are many funding options for evidence-based prevention solutions including at-home drug deactivation and disposal campaigns. In 2021 a $26 billion settlement between the major U.S. drug distributors and drug maker Johnson & Johnson was announced. Distribution will differ by state, and you may have an opportunity to influence how this money is allocated in your jurisdiction. Additionally, State Opioid Response (SOR) and Tribal Opioid Response (TOR) grants are also available for your prevention efforts.
Learn from our expert panel about easy ways to leverage your influence to secure funding to develop impactful prevention activities in your local communities. You’ll also hear firsthand from organization leaders about their successful distribution strategies and tips on how to do the same with your organization.

This Vision Session non-CME presentation is taking place during the Rx Summit. The opinions and recommendations expressed do not necessarily reflect the views of the Rx Summit, Imedex, HMP Global or HMP Education. This program is not intended or eligible for continuing education (CME/CE) credits and does not meet guidelines governing CME/CE. By entering a Vision Session and having your badge scanned, you opt-into share and receive information from industry sponsors. If you wish to opt out, please speak with a conference representative.

This Vision Session is sponsored by Deterra® Drug Deactivation System